Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
29 Gennaio 2025 - 2:07AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Amendment No. 28 to Schedule 13D, dated January 28, 2025, relating to the Common Shares, no par value, of Lineage Cell Therapeutics,
Inc. shall be filed on behalf of the undersigned.
| Dated: January 28, 2025 |
Broadwood Partners, L.P.
|
| |
By: |
Broadwood Capital, Inc. |
| |
|
| |
By: |
/s/ Neal C. Bradsher |
| |
Name: |
Neal C. Bradsher |
| |
Title: |
President |
| |
|
|
| |
|
|
| |
Broadwood Capital, Inc. |
| |
|
| |
By: |
/s/ Neal C. Bradsher |
| |
Name: |
Neal C. Bradsher |
| |
Title: |
President |
| |
|
|
| |
|
|
| |
/s/ Neal C. Bradsher |
| |
Neal C. Bradsher |
Grafico Azioni Lineage Cell Therapeutics (AMEX:LCTX)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Lineage Cell Therapeutics (AMEX:LCTX)
Storico
Da Mar 2024 a Mar 2025
